English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
galactorrhea/dopamine
The link is saved to the clipboard
11 results
6,7,8,9-Tetrahydro-3H-benz(e)indol-7-amines and a method of dopamine receptor stimulation therewith
Only registered users can translate articles
Log In/Sign up
RELATED APPLICATION
Related hereto is U.S. patent application Ser. No. 215,482, filed Dec. 11, 1980, now U.S. Pat. No. 4,370,341.
BACKGROUND OF THE INVENTION
This invention relates to novel 6,7,8,9-tetrahydro-3H-benz[e]indol-7-amine derivatives, to therapeutically acceptable acid addition salts
6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This invention relates to novel 6,7,8,9-tetrahydronaphthol[1,2-b]furan-8-amine derivatives, to therapeutically acceptable acid addition salts thereof, to processes for their preparation, to methods of using the derivatives and to pharmaceutical compositions of the
Pyridoquinoline dopamine agonists, compositions and use
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The ergoline ring is a tetracycle having the following structure ##STR1##
Certain substituted ergolines are known to be D-2 dopamine agonists having the ability to inhibit the secretion of prolactin and to affect favorably the symptoms of Parkinson's Syndrome. For
Method for agonizing a dopamine receptor
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The ergoline ring is a tetracycle having the following structure ##STR1##
Certain substituted ergolines are known to be D-2 dopamine agonists having the ability to inhibit the secretion of prolactin and to affect favorably the symptoms of Parkinson's Syndrome. For
Dopamine agonists method
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
The ergoline ring is a tetracycle having the following structure ##STR1##
Certain substituted ergolines are known to be D-2 dopamine agonists having the ability to inhibit the secretion of prolactin and to affect favorably the symptoms of Parkinson's Syndrome. For
2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This invention relates to novel 2-(4-hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, to therapeutically acceptable acid addition salts thereof, to a process for their preparation, to methods of using the derivatives and to pharmaceutical compositions
2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This invention relates to novel 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, to therapeutically acceptable acid addition salts thereof, to a process for their preparation, to methods of using the derivatives and to pharmaceutical compositions of the
2-(4-Substituted alkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This invention relates to novel 2-(1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives, to therapeutically acceptable acid addition salts thereof, to a process for their preparation, to methods of using the derivatives and to pharmaceutical compositions of the
6,7,8,9-Tetrahydro-3H-benz[E]indol-8-amine derivatives
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This invention relates to novel 6,7,8,9-tetrahydro-3H-benz[e]-indol-8-amine derivatives, to therapeutically acceptable acid addition salts thereof, to processes for their preparation, to methods of using the derivatives and to pharmaceutical compositions of the
6,7,8,9-Tetrahydro-1H-benz(g)indol-8-amine derivatives
Only registered users can translate articles
Log In/Sign up
BACKGROUND OF THE INVENTION
This invention relates to novel 6,7,8,9-tetrahydro-1H-benz[g]indol-8-amine derivatives, to therapeutically acceptable acid addition salts thereof, to processes for their preparation, to methods of using the derivatives and to pharmaceutical compositions of the
Aminoethylthiazole and aminoethyloxazole derivatives
Only registered users can translate articles
Log In/Sign up
The invention relates to aminoethylthiazole and aminoethyloxazole derivatives with the general formula I ##STR2## wherein X is O or S;
ALK is a hydrocarbyl (C.sub.2 -C.sub.6) group;
R.sup.1 is a substituted or unsubstituted aryl group;
R.sup.2 is a hydrogen, a hydrocarbyl (C.sub.1 -C.sub.6) group or
The most complete medicinal herbs database backed by science
- Works in 55 languages
- Herbal cures backed by science
- Herbs recognition by image
- Interactive GPS map - tag herbs on location (coming soon)
- Read scientific publications related to your search
- Search medicinal herbs by their effects
- Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research
